Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients
1 Biomedical Physics Laboratory, Université Libre de Bruxelles; and 2 Chest Department, Erasme University Hospital, Brussels, Belgium Submitted 27 September 2007 ; accepted in final form 16 January 2008 Alveolar nitric oxide (NO) concentration (F A NO ), increasingly considered in asthma, is current...
Gespeichert in:
| Veröffentlicht in: | Journal of applied physiology (1985) 2008-04, Vol.104 (4), p.918-924 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 924 |
|---|---|
| container_issue | 4 |
| container_start_page | 918 |
| container_title | Journal of applied physiology (1985) |
| container_volume | 104 |
| creator | Kerckx, Yannick Michils, Alain Van Muylem, Alain |
| description | 1 Biomedical Physics Laboratory, Université Libre de Bruxelles; and 2 Chest Department, Erasme University Hospital, Brussels, Belgium
Submitted 27 September 2007
; accepted in final form 16 January 2008
Alveolar nitric oxide (NO) concentration (F A NO ), increasingly considered in asthma, is currently interpreted as a reflection of NO production in the alveoli. Recent modeling studies showed that axial molecular diffusion brings NO molecules from the airways back into the alveolar compartment during exhalation (backdiffusion) and contributes to F A NO . Our objectives in this study were 1 ) to simulate the impact of backdiffusion on F A NO and to estimate the alveolar concentration actually due to in situ production (F A NO,prod ); and 2 ) to determine actual alveolar production in stable asthma patients with a broad range of NO bronchial productions. A model incorporating convection and diffusion transport and NO sources was used to simulate F A NO and exhaled NO concentration at 50 ml/s expired flow (F E NO ) for a range of alveolar and bronchial NO productions. F A NO and F E NO were measured in 10 healthy subjects (8 men; age 38 ± 14 yr) and in 21 asthma patients with stable asthma [16 men; age 33 ± 13 yr; forced expiratory volume during 1 s (FEV 1 ) = 98.0 ± 11.9%predicted]. The Asthma Control Questionnaire (Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Chest 115: 1265–1270, 1999) assessed asthma control. Simulations predict that, because of backdiffusion, F A NO and F E NO are linearly related. Experimental results confirm this relationship. F A NO,prod may be derived by F A NO,prod = (F A NO – 0.08·F E NO )/0.92 ( Eq. 1 ). Based on Eq. 1 , F A NO,prod is similar in asthma patients and in healthy subjects. In conclusion, the backdiffusion mechanism is an important determinant of NO alveolar concentration. In stable and unobstructed asthma patients, even with increased bronchial NO production, alveolar production is normal when appropriately corrected for backdiffusion.
exhaled nitric oxide; alveolar nitric oxide; asthma; modeling
Address for reprint requests and other correspondence: A. Van Muylem, Chest Dept., CUB Erasme, 808 Route de Lennik, B-1070 Brussels, Belgium (e-mail: avmuylem{at}ulb.ac.be ) |
| doi_str_mv | 10.1152/japplphysiol.01032.2007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_20257310</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1462251151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-5eaae2d95d0a35b5e8854d4fc766b7de9bc3515847300b34bbc7d0d3622e9db53</originalsourceid><addsrcrecordid>eNp1kM1u1DAUhS0EosPAK4CFBOomg3_jZFlVFJAqsSkrFpb_0njkiYPttM3bN8NEBSGxsnT9nXOvPgDeYbTDmJNPezWOYezn7GPYIYwo2RGExDOwWX5JhWuEn4NNIziqBG_EGXiV8x4hzBjHL8EZbghuWiw24OeFT_dqhiYOJXk9FR8HWCJU4c7FoBIc_DI3MD5466AfYO9UKP0M86T3zpQM1WBhLkoHB1Uu_UHBURXvhpJfgxedCtm9Wd8t-HH1-ebya3X9_cu3y4vrynBMSsWdUo7YllukKNfcNQ1nlnVG1LUW1rXaUI55wwRFSFOmtREWWVoT4lqrOd2Cj6feMcVfk8tFHnw2LgQ1uDhlKRCrG8roAr7_B9zHKQ3LbZIQgmvOhFggcYJMijkn18kx-YNKs8RIHuXLv-XL3_LlUf6SfLvWT_rg7J_cansBPqyAykaFLqnB-PzEEUS4oEvfFrAT1_vb_t4nJ9dt8XaWV1MIN-6hHM_AiEkmW9zI0XZL7Pz_sYWWTzh9BIQns1k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222165477</pqid></control><display><type>article</type><title>Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients</title><source>MEDLINE</source><source>American Physiological Society Paid</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Kerckx, Yannick ; Michils, Alain ; Van Muylem, Alain</creator><creatorcontrib>Kerckx, Yannick ; Michils, Alain ; Van Muylem, Alain</creatorcontrib><description>1 Biomedical Physics Laboratory, Université Libre de Bruxelles; and 2 Chest Department, Erasme University Hospital, Brussels, Belgium
Submitted 27 September 2007
; accepted in final form 16 January 2008
Alveolar nitric oxide (NO) concentration (F A NO ), increasingly considered in asthma, is currently interpreted as a reflection of NO production in the alveoli. Recent modeling studies showed that axial molecular diffusion brings NO molecules from the airways back into the alveolar compartment during exhalation (backdiffusion) and contributes to F A NO . Our objectives in this study were 1 ) to simulate the impact of backdiffusion on F A NO and to estimate the alveolar concentration actually due to in situ production (F A NO,prod ); and 2 ) to determine actual alveolar production in stable asthma patients with a broad range of NO bronchial productions. A model incorporating convection and diffusion transport and NO sources was used to simulate F A NO and exhaled NO concentration at 50 ml/s expired flow (F E NO ) for a range of alveolar and bronchial NO productions. F A NO and F E NO were measured in 10 healthy subjects (8 men; age 38 ± 14 yr) and in 21 asthma patients with stable asthma [16 men; age 33 ± 13 yr; forced expiratory volume during 1 s (FEV 1 ) = 98.0 ± 11.9%predicted]. The Asthma Control Questionnaire (Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Chest 115: 1265–1270, 1999) assessed asthma control. Simulations predict that, because of backdiffusion, F A NO and F E NO are linearly related. Experimental results confirm this relationship. F A NO,prod may be derived by F A NO,prod = (F A NO – 0.08·F E NO )/0.92 ( Eq. 1 ). Based on Eq. 1 , F A NO,prod is similar in asthma patients and in healthy subjects. In conclusion, the backdiffusion mechanism is an important determinant of NO alveolar concentration. In stable and unobstructed asthma patients, even with increased bronchial NO production, alveolar production is normal when appropriately corrected for backdiffusion.
exhaled nitric oxide; alveolar nitric oxide; asthma; modeling
Address for reprint requests and other correspondence: A. Van Muylem, Chest Dept., CUB Erasme, 808 Route de Lennik, B-1070 Brussels, Belgium (e-mail: avmuylem{at}ulb.ac.be )</description><identifier>ISSN: 8750-7587</identifier><identifier>EISSN: 1522-1601</identifier><identifier>DOI: 10.1152/japplphysiol.01032.2007</identifier><identifier>PMID: 18218917</identifier><identifier>CODEN: JAPHEV</identifier><language>eng</language><publisher>Bethesda, MD: Am Physiological Soc</publisher><subject>Adult ; Airway management ; Algorithms ; Asthma ; Asthma - metabolism ; Biological and medical sciences ; Bronchi - metabolism ; Bronchi - physiology ; Diffusion ; Forced Expiratory Volume - physiology ; Fundamental and applied biological sciences. Psychology ; Helium ; Humans ; Linear Models ; Luminescence ; Male ; Middle Aged ; Models, Statistical ; Nitric oxide ; Nitric Oxide - metabolism ; Oxygen ; Pulmonary Alveoli - metabolism ; Respiratory Physiological Phenomena ; Respiratory System ; Simulation</subject><ispartof>Journal of applied physiology (1985), 2008-04, Vol.104 (4), p.918-924</ispartof><rights>2008 INIST-CNRS</rights><rights>Copyright American Physiological Society Apr 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-5eaae2d95d0a35b5e8854d4fc766b7de9bc3515847300b34bbc7d0d3622e9db53</citedby><cites>FETCH-LOGICAL-c512t-5eaae2d95d0a35b5e8854d4fc766b7de9bc3515847300b34bbc7d0d3622e9db53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3039,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20257310$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18218917$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kerckx, Yannick</creatorcontrib><creatorcontrib>Michils, Alain</creatorcontrib><creatorcontrib>Van Muylem, Alain</creatorcontrib><title>Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients</title><title>Journal of applied physiology (1985)</title><addtitle>J Appl Physiol (1985)</addtitle><description>1 Biomedical Physics Laboratory, Université Libre de Bruxelles; and 2 Chest Department, Erasme University Hospital, Brussels, Belgium
Submitted 27 September 2007
; accepted in final form 16 January 2008
Alveolar nitric oxide (NO) concentration (F A NO ), increasingly considered in asthma, is currently interpreted as a reflection of NO production in the alveoli. Recent modeling studies showed that axial molecular diffusion brings NO molecules from the airways back into the alveolar compartment during exhalation (backdiffusion) and contributes to F A NO . Our objectives in this study were 1 ) to simulate the impact of backdiffusion on F A NO and to estimate the alveolar concentration actually due to in situ production (F A NO,prod ); and 2 ) to determine actual alveolar production in stable asthma patients with a broad range of NO bronchial productions. A model incorporating convection and diffusion transport and NO sources was used to simulate F A NO and exhaled NO concentration at 50 ml/s expired flow (F E NO ) for a range of alveolar and bronchial NO productions. F A NO and F E NO were measured in 10 healthy subjects (8 men; age 38 ± 14 yr) and in 21 asthma patients with stable asthma [16 men; age 33 ± 13 yr; forced expiratory volume during 1 s (FEV 1 ) = 98.0 ± 11.9%predicted]. The Asthma Control Questionnaire (Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Chest 115: 1265–1270, 1999) assessed asthma control. Simulations predict that, because of backdiffusion, F A NO and F E NO are linearly related. Experimental results confirm this relationship. F A NO,prod may be derived by F A NO,prod = (F A NO – 0.08·F E NO )/0.92 ( Eq. 1 ). Based on Eq. 1 , F A NO,prod is similar in asthma patients and in healthy subjects. In conclusion, the backdiffusion mechanism is an important determinant of NO alveolar concentration. In stable and unobstructed asthma patients, even with increased bronchial NO production, alveolar production is normal when appropriately corrected for backdiffusion.
exhaled nitric oxide; alveolar nitric oxide; asthma; modeling
Address for reprint requests and other correspondence: A. Van Muylem, Chest Dept., CUB Erasme, 808 Route de Lennik, B-1070 Brussels, Belgium (e-mail: avmuylem{at}ulb.ac.be )</description><subject>Adult</subject><subject>Airway management</subject><subject>Algorithms</subject><subject>Asthma</subject><subject>Asthma - metabolism</subject><subject>Biological and medical sciences</subject><subject>Bronchi - metabolism</subject><subject>Bronchi - physiology</subject><subject>Diffusion</subject><subject>Forced Expiratory Volume - physiology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Helium</subject><subject>Humans</subject><subject>Linear Models</subject><subject>Luminescence</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Models, Statistical</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - metabolism</subject><subject>Oxygen</subject><subject>Pulmonary Alveoli - metabolism</subject><subject>Respiratory Physiological Phenomena</subject><subject>Respiratory System</subject><subject>Simulation</subject><issn>8750-7587</issn><issn>1522-1601</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1u1DAUhS0EosPAK4CFBOomg3_jZFlVFJAqsSkrFpb_0njkiYPttM3bN8NEBSGxsnT9nXOvPgDeYbTDmJNPezWOYezn7GPYIYwo2RGExDOwWX5JhWuEn4NNIziqBG_EGXiV8x4hzBjHL8EZbghuWiw24OeFT_dqhiYOJXk9FR8HWCJU4c7FoBIc_DI3MD5466AfYO9UKP0M86T3zpQM1WBhLkoHB1Uu_UHBURXvhpJfgxedCtm9Wd8t-HH1-ebya3X9_cu3y4vrynBMSsWdUo7YllukKNfcNQ1nlnVG1LUW1rXaUI55wwRFSFOmtREWWVoT4lqrOd2Cj6feMcVfk8tFHnw2LgQ1uDhlKRCrG8roAr7_B9zHKQ3LbZIQgmvOhFggcYJMijkn18kx-YNKs8RIHuXLv-XL3_LlUf6SfLvWT_rg7J_cansBPqyAykaFLqnB-PzEEUS4oEvfFrAT1_vb_t4nJ9dt8XaWV1MIN-6hHM_AiEkmW9zI0XZL7Pz_sYWWTzh9BIQns1k</recordid><startdate>20080401</startdate><enddate>20080401</enddate><creator>Kerckx, Yannick</creator><creator>Michils, Alain</creator><creator>Van Muylem, Alain</creator><general>Am Physiological Soc</general><general>American Physiological Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20080401</creationdate><title>Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients</title><author>Kerckx, Yannick ; Michils, Alain ; Van Muylem, Alain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-5eaae2d95d0a35b5e8854d4fc766b7de9bc3515847300b34bbc7d0d3622e9db53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Airway management</topic><topic>Algorithms</topic><topic>Asthma</topic><topic>Asthma - metabolism</topic><topic>Biological and medical sciences</topic><topic>Bronchi - metabolism</topic><topic>Bronchi - physiology</topic><topic>Diffusion</topic><topic>Forced Expiratory Volume - physiology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Helium</topic><topic>Humans</topic><topic>Linear Models</topic><topic>Luminescence</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Models, Statistical</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - metabolism</topic><topic>Oxygen</topic><topic>Pulmonary Alveoli - metabolism</topic><topic>Respiratory Physiological Phenomena</topic><topic>Respiratory System</topic><topic>Simulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kerckx, Yannick</creatorcontrib><creatorcontrib>Michils, Alain</creatorcontrib><creatorcontrib>Van Muylem, Alain</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of applied physiology (1985)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kerckx, Yannick</au><au>Michils, Alain</au><au>Van Muylem, Alain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients</atitle><jtitle>Journal of applied physiology (1985)</jtitle><addtitle>J Appl Physiol (1985)</addtitle><date>2008-04-01</date><risdate>2008</risdate><volume>104</volume><issue>4</issue><spage>918</spage><epage>924</epage><pages>918-924</pages><issn>8750-7587</issn><eissn>1522-1601</eissn><coden>JAPHEV</coden><abstract>1 Biomedical Physics Laboratory, Université Libre de Bruxelles; and 2 Chest Department, Erasme University Hospital, Brussels, Belgium
Submitted 27 September 2007
; accepted in final form 16 January 2008
Alveolar nitric oxide (NO) concentration (F A NO ), increasingly considered in asthma, is currently interpreted as a reflection of NO production in the alveoli. Recent modeling studies showed that axial molecular diffusion brings NO molecules from the airways back into the alveolar compartment during exhalation (backdiffusion) and contributes to F A NO . Our objectives in this study were 1 ) to simulate the impact of backdiffusion on F A NO and to estimate the alveolar concentration actually due to in situ production (F A NO,prod ); and 2 ) to determine actual alveolar production in stable asthma patients with a broad range of NO bronchial productions. A model incorporating convection and diffusion transport and NO sources was used to simulate F A NO and exhaled NO concentration at 50 ml/s expired flow (F E NO ) for a range of alveolar and bronchial NO productions. F A NO and F E NO were measured in 10 healthy subjects (8 men; age 38 ± 14 yr) and in 21 asthma patients with stable asthma [16 men; age 33 ± 13 yr; forced expiratory volume during 1 s (FEV 1 ) = 98.0 ± 11.9%predicted]. The Asthma Control Questionnaire (Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Chest 115: 1265–1270, 1999) assessed asthma control. Simulations predict that, because of backdiffusion, F A NO and F E NO are linearly related. Experimental results confirm this relationship. F A NO,prod may be derived by F A NO,prod = (F A NO – 0.08·F E NO )/0.92 ( Eq. 1 ). Based on Eq. 1 , F A NO,prod is similar in asthma patients and in healthy subjects. In conclusion, the backdiffusion mechanism is an important determinant of NO alveolar concentration. In stable and unobstructed asthma patients, even with increased bronchial NO production, alveolar production is normal when appropriately corrected for backdiffusion.
exhaled nitric oxide; alveolar nitric oxide; asthma; modeling
Address for reprint requests and other correspondence: A. Van Muylem, Chest Dept., CUB Erasme, 808 Route de Lennik, B-1070 Brussels, Belgium (e-mail: avmuylem{at}ulb.ac.be )</abstract><cop>Bethesda, MD</cop><pub>Am Physiological Soc</pub><pmid>18218917</pmid><doi>10.1152/japplphysiol.01032.2007</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 8750-7587 |
| ispartof | Journal of applied physiology (1985), 2008-04, Vol.104 (4), p.918-924 |
| issn | 8750-7587 1522-1601 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_20257310 |
| source | MEDLINE; American Physiological Society Paid; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Adult Airway management Algorithms Asthma Asthma - metabolism Biological and medical sciences Bronchi - metabolism Bronchi - physiology Diffusion Forced Expiratory Volume - physiology Fundamental and applied biological sciences. Psychology Helium Humans Linear Models Luminescence Male Middle Aged Models, Statistical Nitric oxide Nitric Oxide - metabolism Oxygen Pulmonary Alveoli - metabolism Respiratory Physiological Phenomena Respiratory System Simulation |
| title | Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A02%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Airway%20contribution%20to%20alveolar%20nitric%20oxide%20in%20healthy%20subjects%20and%20stable%20asthma%20patients&rft.jtitle=Journal%20of%20applied%20physiology%20(1985)&rft.au=Kerckx,%20Yannick&rft.date=2008-04-01&rft.volume=104&rft.issue=4&rft.spage=918&rft.epage=924&rft.pages=918-924&rft.issn=8750-7587&rft.eissn=1522-1601&rft.coden=JAPHEV&rft_id=info:doi/10.1152/japplphysiol.01032.2007&rft_dat=%3Cproquest_pasca%3E1462251151%3C/proquest_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222165477&rft_id=info:pmid/18218917&rfr_iscdi=true |